ESR1 Mutations Provide Window Into Breast Cancer Metastasis

Via Peters

Present in approximately two-thirds of estrogen receptor-positive breast cancers, the role of ESR1 mutations in disease metastasis is poorly defined. Present in approximately two-thirds of estrogen receptor (ER)-positive breast cancers, the role of ESR1 mutations in disease metastasis is poorly defined.1 “It is an important research area because it is […]

Prognostic biomarkers for postoperative metastasis

Via Peters

Introduction Female breast cancer is the most commonly diagnosed cancer in the world, and more than 2.3 million women are diagnosed in 2020 and are still the leading cause of cancer death.1 Invasive breast carcinoma (BC) accounts for 80–90% of breast cancer and is the most common type of pathology […]